Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma

키워드

참고문헌 (17)

1. Seulki Lee, "Inhibition of PI3K", Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail, beta-catenin pathway, pp.Clinical and Molecular Hepatology, 2020[DOI]
2. Hay ED, "An overview of epithelio-mesenchymal transformation", Acta Anat(Basel), 154, pp.8~20 (1995)
3. Nieto MA, "EMT: 2016", Cell, 166, pp.21~45 (2016)
4. Puisieux A, "Oncogenic roles of EMT-inducing transcription factors", Nat Cell Biol, 16, pp.488~494 (2014)
5. Loh CY, "The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition : signaling, therapeutic implications, and challenges", Cells, 8, pp.1118~ (2019)
6. Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
7. Vogel A, "Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma", Cancer Treat Rev, 82, pp.101946~ (2020)
8. Giannelli G, "Role of epithelial to mesenchymal transition in hepatocellular carcinoma", J Hepatol, 65, pp.798~808 (2016)
9. 정연상, "Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex", Experimental and Molecular Medicine, 52, pp.1~9 (2020), 생화학분자생물학회[DOI]
10. Martin-Orozco E, "WNT signaling in tumors : the way to evade drugs and immunity", Front Immunol, 10, pp.2854~ (2019)
11. Manning BD, "AKT", PKB signaling : navigating the network, 2017, pp.169, 381~405
12. Burger JA, "Haematological cancer : idelalisib-targeting PI3Kδ in patients with B-cell malignancies", Nat Rev Clin Oncol, 11, pp.184~186 (2014)
13. Yang Q, "Idelalisib : first-inclass PI3K delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma", Clin Cancer Res, 21, pp.1537~1542 (2015)
14. Cheah CY, "Idelalisib in the management of lymphoma", Blood, 128, pp.331~336 (2016)
15. Grille SJ, "The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines", Cancer Res, 63, pp.2172~2178 (2003)
16. Larue L, "Epithelial-mesenchymal transition in development and cancer : role of phosphatidylinositol 3’ kinase", AKT pathways, 2005, pp.24, 7443~7454
17. Cervello M, "Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma", Adv Biol Regul, 65, pp.59~76 (2017)

관련 논문AI추천